Abbvie Inc’s recent filing unveils that its EVP, CHIEF COMMERCIAL OFFICER Stewart Jeffrey Ryan unloaded Company’s shares for reported $12.36 million on Mar 31 ’25. In the deal valued at $210.08 per share,58,832 shares were sold. As a result of this transaction, Stewart Jeffrey Ryan now holds 53,234 shares worth roughly $9.78 million.
Then, Stewart Jeffrey Ryan bought 58,832 shares, generating $12,359,897 in total proceeds.
Before that, Reents Scott T sold 17,644 shares. Abbvie Inc shares valued at $3,746,527 were divested by the EVP, CHIEF FINANCIAL OFFICER at a price of $212.34 per share. As a result of the transaction, Reents Scott T now holds 11,577 shares, worth roughly $2.13 million.
Citigroup downgraded its Abbvie Inc [ABBV] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Daiwa Securities revised its rating on December 05, 2024. It rated ABBV as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of ABBV
On Monday, Abbvie Inc [NYSE:ABBV] saw its stock fall -0.83%% to $183.76. Over the last five days, the stock has lost -3.83%. Abbvie Inc shares have risen nearly 7.24% since the year began. Nevertheless, the stocks have risen 3.41% over the past one year. While a 52-week high of $218.66 was reached on 03/10/25, a 52-week low of $163.52 was recorded on 04/09/25.
Levels Of Support And Resistance For ABBV Stock
The 24-hour chart illustrates a support level at 182.11, which if violated will result in even more drops to 180.45. On the upside, there is a resistance level at 185.61. A further resistance level may holdings at 187.45.
